Home > Balance Sheet > NEULAND LABORATORIES

NEULAND LABORATORIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹69 Cr₹73 Cr₹60 Cr₹58 Cr₹57 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of NEULAND LABORATORIES ?

The latest Deferred Tax Assets / Liabilities ratio of NEULAND LABORATORIES is ₹69 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹69 Cr
Mar2025₹73 Cr
Mar2024₹60 Cr
Mar2023₹58 Cr
Mar2022₹57 Cr

How is Deferred Tax Assets / Liabilities of NEULAND LABORATORIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹69 Cr
-5.30
Mar2025 ₹73 Cr
20.49
Mar2024 ₹60 Cr
3.67
Mar2023 ₹58 Cr
2.82
Mar2022 ₹57 Cr -

Compare Deferred Tax Assets / Liabilities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹26,984.6 Cr 6.1% 4.4% 15.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,291.0 Cr -1.8% 7.6% 11.2% Stock Analytics
DIVIS LABORATORIES ₹305,014.0 Cr 3.7% 27.2% 71.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,333.0 Cr -2.3% 1.5% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,017.0 Cr 0.6% 13.4% 15.7% Stock Analytics
CIPLA ₹112,539.0 Cr -1.3% 6.1% -6.9% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

6.1%

4.4%

15.5%

SENSEX

0.7%

11.7%

-2%


You may also like the below Video Courses